Showing results (41-50 of 63) with videos related to
Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|August 9, 2011
Allogeneic HLA-A*02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuityWillem J J Falkenburg, J Joseph Melenhorst, Marian van de Meent, et al.Blood|February 25, 2006
Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancerElisabeth H Slager, M Willy Honders, Edith D van der Meijden, et al.Journal for Immunotherapy of Cancer|March 26, 2024
Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trialRenske M T Ten Ham, Maartje W Rohaan, Inge Jedema, et al.American Journal of Hematology|October 30, 2018
Loss of the GPI-anchor in B-lymphoblastic leukemia by epigenetic downregulation of PIGH expressionFloris C Loeff, Kevin Rijs, Esther H M van Egmond, et al.Frontiers in Immunology|January 9, 2019
CD4 Donor Lymphocyte Infusion Can Cause Conversion of Chimerism Without GVHD by Inducing Immune Responses Targeting Minor Histocompatibility Antigens in HLA Class IIPeter van Balen, Cornelis A M van Bergen, Simone A P van Luxemburg-Heijs, et al.Blood|January 20, 2007
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) geneCornelis A M van Bergen, Michel G D Kester, Inge Jedema, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Phenotypic and Functional Characteristics of CD8+ T cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced MelanomaJoachim S Granhøj, Sigrid M H Mannering, Kasper Madsen, et al.Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Human T cells recognize HLA-DP-bound peptides in two orientationsSebastian Klobuch, Jia Jia Lim, Peter van Balen, et al.Frontiers in Immunology|September 25, 2020
HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical StudyPeter van Balen, Inge Jedema, Marleen M van Loenen, et al.Transplantation and Cellular Therapy|January 1, 2023
Competitive Repopulation and Allo-Immunologic Pressure Determine Chimerism Kinetics after T Cell-Depleted Allogeneic Stem Cell Transplantation and Donor Lymphocyte InfusionEva A S Koster, Peter A von dem Borne, Peter van Balen, et al.Pageof 7